Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Semaglutide Biosimilar and Generic Market Size, Share and Trends Analysis Distribution by Product Type (Semaglutide Injectable Generic (Subcutaneous), Semaglutide Oral Tablet Generic, Semaglutide Biosimilar (Biologic Pathway), Semaglutide Peptide API (Merchant Supply), Co-Formulated and Fixed-Dose Combination Generics), By Dosage Form (Disposable Multi-Dose Prefilled Pen, Single-Use Prefilled Autoinjector, Multi-Dose Vials, Single-Dose Vials, Prefilled Cartridges for Reusable Pens, Oral Tablets (Immediate Release)), By Dose Strength (Subcutaneous Injection, Oral Tablet) and Segment Forecasts, 2026 to 2035
The brain learns that contact with injection materials does not result in the feared outcome, gradually extinguishing the anxiety response
Clinically significant weight loss of at least 5% was achieved by 89% and 91% of participants, while 6771% lost at least 15% of their body weight
No safety issues emerged [87]
US$ 26.53
US$ 21.15
US$ 23.68
